Holen Sie sich die Stockscreener-App
2.4531
12.56%
0.2731
Schlusskurs vom Vortag:
$2.18
Offen:
$2.34
24-Stunden-Volumen:
8.27M
Relative Volume:
0.92
Marktkapitalisierung:
$1.02B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$-123.70M
KGV:
-9.2118
EPS:
-0.2663
Netto-Cashflow:
$-178.21M
1W Leistung:
-14.80%
1M Leistung:
-15.97%
6M Leistung:
-44.74%
1J Leistung:
+31.92%
1-Tages-Spanne:
$2.34
$2.53
1-Wochen-Bereich:
$2.12
$2.97
52-Wochen-Spanne:
$1.84
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Vergleichen Sie CLOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.455 | 1.11B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
254.13 | 227.59B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.03 | 80.56B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
276.48 | 72.06B | 260.93B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
291.80 | 62.22B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
268.08 | 30.86B | 117.76B | 1.21B | 2.39B | 9.95 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential (NASDAQ:CLOV) - Seeking Alpha
Clover Health Stock (CLOV): Insider Confidence Sparks Rally - Value The Markets
Co-Founder & Executive Chairman of Clover Health Investments Vivek Garipalli Buys 32% More Shares - simplywall.st
Clover drops despite Q2 beat amid concerns over medical cost trends - MSN
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Earnings Call: Growth and Profitability Insights - The Globe and Mail
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript - Insider Monkey
Clover Health shares rise 1.33% premarket after 2Q25 earnings call and UBS price target adjustment. - AInvest
Clover Health CEO Reynoso sells $19,718 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $19,718 in shares - Investing.com India
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates - MSN
Clover Health stock drops on Q2 report release - Nashville Post
Clover stock drops despite Q2 beat (CLOV:NASDAQ) - Seeking Alpha
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View - Yahoo Finance
UBS Adjusts Price Target on Clover Health Investments to $3 From $4.50, Maintains Neutral Rating - MarketScreener
Community Health Systems, Inc. shares fall 1.61% premarket after Clover Health reports Q2 loss. - AInvest
Clover Health shares fall 11.58% premarket after reporting a Q2 loss of $10.58 million. - AInvest
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call Highlights: Surpassing Growth ... - Yahoo Finance
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call High - GuruFocus
Clover Health Reports Strong Q2 2025 Growth - TipRanks
Clover Health (CLOV) Q2 Sales Up 34% - AOL.com
Clover Health Investments Q2 2025 Earnings Call Transcript - AInvest
Clover Health Investments earnings beat by $0.05, revenue topped estimates By Investing.com - Investing.com South Africa
Clover Health Posts Rising Revenue And Beats Profit Targets - Finimize
Earnings call transcript: Clover Health Q2 2025 sees revenue beat, stock dips - Investing.com
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details - 富途牛牛
Clover Health (NASDAQ:CLOV) Beats Q2 Sales Targets But Stock Drops - Yahoo Finance
Clover Health Investments Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Clover Health Q2 revenue beats expectations - MarketScreener
Clover Health Q2 2025 slides: 32% membership growth amid sustained profitability - Investing.com Nigeria
Earnings Flash (CLOV) Clover Health Investments, Corp. Reports Q2 Revenue $477.6M, vs. FactSet Est of $468.3M - MarketScreener
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth - The Manila Times
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | CLOV SEC FilingForm 8-K - Stock Titan
Clover Health Investments, Corp. shares rise 1.74% premarket after small business sales tick up in July. - AInvest
Counterpart Health Releases Whitepaper Linking AI-Powered Assistant to Improved COPD Management and Reduced Hospitalizations - Quiver Quantitative
Groundbreaking Study: AI Assistant Cuts COPD Hospital Readmissions by 18%, Transforms Patient Care - Stock Titan
What To Expect From Clover Health Investments Corp (CLOV) Q2 2025 Earnings - Yahoo Finance
Is Clover Health Investments Corp. stock reversal real or fakeDaily Stock Forecast Powered by AI Tools - Newser
Clover Health (CLOV) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
How does Clover Health Investments Corp. compare to its industry peersFree Stock Market Return Analysis - Jammu Links News
What is Clover Health Investments Corp. company’s growth strategyFree Popular Stock Recommendations - Jammu Links News
What are analysts’ price targets for Clover Health Investments Corp. in the next 12 monthsFree Daily Trading Room Entry - Jammu Links News
When is Clover Health Investments Corp. stock expected to show significant growthMassive wealth growth - Jammu Links News
What are Clover Health Investments Corp. company’s key revenue driversSuperior risk-adjusted returns - Jammu Links News
What catalysts could drive Clover Health Investments Corp. stock higher in 2025Over 200% growth - Jammu Links News
What are the technical indicators suggesting about Clover Health Investments Corp.Robust investment performance - Jammu Links News
Should I hold or sell Clover Health Investments Corp. stock in 2025Fastest return on investment - Jammu Links News
Is it the right time to buy Clover Health Investments Corp. stockCapitalize on emerging market sectors - Jammu Links News
How does Clover Health Investments Corp. generate profit in a changing economySuperior returns - Jammu Links News
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clover Health Investments Corp-Aktie (CLOV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Garipalli Vivek | Director |
Aug 08 '25 |
Buy |
2.17 |
31,980 |
69,397 |
1,856,247 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Aug 04 '25 |
Sale |
2.89 |
6,823 |
19,718 |
3,261,485 |
4.40%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):